These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1933313)

  • 1. A possible fetal antigen of Mr 70,000 in neurofibrillary tangles.
    Morishima-Kawashima M; Arai T; Ogawara M; Takio K; Titani K; Saitoh T; Kosik KS; Ihara Y
    Brain Res; 1991 Jul; 554(1-2):316-20. PubMed ID: 1933313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the association of protein 4.1 immunoreactive forms with neurofibrillary tangles in Alzheimer's disease brains.
    Sihag RK; Wang LW; Cataldo AM; Hamlin M; Cohen CM; Nixon RA
    Brain Res; 1994 Sep; 656(1):14-26. PubMed ID: 7804827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain.
    Wang D; Munoz DG
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):548-56. PubMed ID: 7602328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein.
    Hanger DP; Mann DM; Neary D; Anderton BH
    Biochem Soc Trans; 1992 Aug; 20(3):642-5. PubMed ID: 1426605
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
    Layfield R; Fergusson J; Aitken A; Lowe J; Landon M; Mayer RJ
    Neurosci Lett; 1996 May; 209(1):57-60. PubMed ID: 8734909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease.
    Hasegawa M; Arai T; Ihara Y
    Neuron; 1990 Jun; 4(6):909-18. PubMed ID: 2361014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions.
    de la Monte SM; Wands JR
    J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
    Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
    Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.
    Masliah E; Mallory M; Alford M; Hansen LA; Saitoh T
    Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of septins in neurofibrillary tangles in Alzheimer's disease.
    Kinoshita A; Kinoshita M; Akiyama H; Tomimoto H; Akiguchi I; Kumar S; Noda M; Kimura J
    Am J Pathol; 1998 Nov; 153(5):1551-60. PubMed ID: 9811347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer disease: curly fibers and tangles in organs other than brain.
    Miklossy J; Taddei K; Martins R; Escher G; Kraftsik R; Pillevuit O; Lepori D; Campiche M
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):803-14. PubMed ID: 10446805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoskeletal abnormalities in Alzheimer's disease.
    Lovestone S; Anderton B
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):883-8. PubMed ID: 1467582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.
    Nukina N; Kosik KS; Selkoe DJ
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3415-9. PubMed ID: 3106969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.
    Nukina N; Kosik KS; Selkoe DJ
    Neurosci Lett; 1988 May; 87(3):240-6. PubMed ID: 3132653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5.
    Takahashi H; Hirokawa K; Ando S; Obata K
    Acta Neuropathol; 1991; 81(6):626-31. PubMed ID: 1909079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
    Schnurra I; Bernstein HG; Riederer P; Braunewell KH
    Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.